RxDoctor Payments Data

Aubrey Galloway, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1982696696

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $5,708,624 of the $5,726,916 with a category attached, or 99.7%. Medtronic accounts for 99.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $1,134,256 and has fallen 62.5% since, to $425,239 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,726,916in general payments, 2019–2025

Across 129 payments — averaging $44,395 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5.7M
  • Edwards Lifesciences$31K
  • Abbott$268
  • Baxter Healthcare$194
  • Abiomed$167
  • Pfizer$49
  • plus $90 from 3 others
$12,091in research payments, 2019–2025

Across 17 payments — averaging $711.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$12K

What the payments were for

  • Royalty or licence$5,708,624100%
  • Speaking & faculty fees$15,0000%
  • Travel & lodging$8940%
  • Food & beverage$2,3980%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)105$5,695,079
Edwards Lifesciences7$31,069
Abbott3$268
Baxter Healthcare7$194
Abiomed1$167
Pfizer2$49
Atricure, Inc.2$43
Kiniksa Pharmaceuticals, Ltd.1$24
Zimmer Biomet1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,726,916 in reported general payments places this provider in the 95th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York

Medicare billing

Part B allowed, 2024
$53,746
Medicare patients
51
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →